Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04019327
Title A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center

prostate adenocarcinoma


Talazoparib + Temozolomide

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST